Rosenblatt maintains Calix at Buy, keeps price target at $55

What happened

Rosenblatt maintained its Buy rating on Calix and kept its price target at $55. The target implies 65.4% upside from Calix’s Nov. 3 closing price of $33.25, according to the supplied article.

Confirmed

Global impact / market context

The unchanged Buy rating and target signal that Rosenblatt has not revised its view in this update. The stated gap between the target and closing price may shape investor expectations, but it is an analyst estimate, not a guaranteed return or company performance forecast.

Analyst inference

The article reports one broker’s rating and target, not a change in Calix’s business results or a company announcement. Its 65.4% implied upside is calculated from the cited Nov. 3 close, so it depends on that reference price and Rosenblatt’s estimate.

Analyst inference

What to watch

1. Check whether Rosenblatt later changes its Buy rating or $55 target; a revision would show that its published view of Calix has shifted. Analyst inference
2. Compare future company results or guidance, if reported, with the expectations implied by the target; the article provides no operating forecast or financial results. Analyst inference
3. The article confirms the target uses the Nov. 3 close of $33.25 as its comparison price; it gives no later share price or realized return. Confirmed

Evidence

• Original source link unavailable